Santhanam Subramanian - Aurobindo Pharma Chief Officer
| AUROPHARMA | 1,238 14.45 1.18% |
Executive
Santhanam Subramanian is Chief Officer of Aurobindo Pharma Limited
| Age | 63 |
| Phone | 91 40 6672 5000 |
| Web | https://www.aurobindo.com |
Aurobindo Pharma Management Efficiency
The company has return on total asset (ROA) of 0.0677 % which means that it generated a profit of $0.0677 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1213 %, meaning that it generated $0.1213 on every $100 dollars invested by stockholders. Aurobindo Pharma's management efficiency ratios could be used to measure how well Aurobindo Pharma manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Rohit Goyal | Kewal Kiran Clothing | 43 | |
| Shirish Suvagia | MIRC Electronics Limited | 44 | |
| J Suresh | EIH Associated Hotels | 59 | |
| Abhijit CS | Kewal Kiran Clothing | 46 | |
| Deepak Sarawagi | MIRC Electronics Limited | N/A | |
| Ranabir Sanyal | Royal Orchid Hotels | 39 | |
| Devendra Bhatnagar | Asian Hotels Limited | N/A | |
| Lakhbir Singh | Kewal Kiran Clothing | 44 | |
| Vikas Passi | Royal Orchid Hotels | N/A | |
| Philip Logan | Royal Orchid Hotels | N/A | |
| Niraj Agarwal | Iris Clothings Limited | N/A | |
| Samidh Das | EIH Associated Hotels | 57 | |
| Ashok Kheny | BF Utilities Limited | 74 | |
| Akila | Oriental Hotels Limited | N/A | |
| Ramvir Singh | Asian Hotels Limited | N/A | |
| Shivakumar Kheny | BF Utilities Limited | 76 | |
| Sreyas Arumbakkam | Oriental Hotels Limited | N/A | |
| Aseem Kapoor | Asian Hotels Limited | 55 | |
| Amit Jaiswal | Royal Orchid Hotels | N/A | |
| Himanshu Pant | Kewal Kiran Clothing | 57 | |
| Niraj Tanwar | EIH Associated Hotels | 47 | |
Management Performance
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0677 |
Aurobindo Pharma Leadership Team
Elected by the shareholders, the Aurobindo Pharma's board of directors comprises two types of representatives: Aurobindo Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aurobindo. The board's role is to monitor Aurobindo Pharma's management team and ensure that shareholders' interests are well served. Aurobindo Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aurobindo Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Rama Rao, President QA | ||
| Venugopalan Muralidharan, President Business | ||
| Ravikiran, Chief Officer | ||
| G Prasad, Senior Operations | ||
| Penaka Reddy, WholeTime Director | ||
| Vijaya Kumar, President Technical | ||
| Sanjay MSc, Chief Limited | ||
| Meenakshi Sivakumaran, WholeTime Director | ||
| Damodharan, Chief vertical | ||
| Kambam Reddy, Vice MD | ||
| Swami Iyer, Chief America | ||
| Sudhir Singhi, Head Operations | ||
| BE MBA, CEO Biologics | ||
| Mettu Reddy, WholeTime Director | ||
| Arvind Bothra, Head Communications | ||
| Sanjeev Dani, COO Formulations | ||
| Puvvala Yugandhar, CEO Specialities | ||
| Shriniwas Dange, Investor Executive | ||
| Adi Reddy, Compliance Secretary | ||
| Santhanam Subramanian, Chief Officer | ||
| V Handa, President Research |
Aurobindo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aurobindo Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0677 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 721.95 B | |||
| Shares Outstanding | 580.8 M | |||
| Shares Owned By Insiders | 52.35 % | |||
| Shares Owned By Institutions | 30.54 % | |||
| Price To Book | 2.31 X | |||
| Price To Sales | 2.35 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Aurobindo Stock
Aurobindo Pharma financial ratios help investors to determine whether Aurobindo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aurobindo with respect to the benefits of owning Aurobindo Pharma security.